 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter D - Drugs for Human Use |
|
|
Part 369 - Interpretative Statements Re Warnings on Drugs and Devices for over-the-Counter Sale |
| Subpart A - Definitions and Interpretations |
| § 369.1 - Purpose of issuance. |
| § 369.2 - Definitions. |
| § 369.3 - Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C). |
| § 369.4 - Warnings suggested for drugs by formal or informal statements of policy. |
| § 369.5 - Warnings required on insulin intended for over-the-counter sale. |
| § 369.6 - [Reserved] |
| § 369.7 - Warnings required by official compendia. |
| § 369.8 - Warning statements in relation to conditions for use. |
| § 369.9 - General warnings re accidental ingestion by children. |
| § 369.10 - Conspicuousness of warning statements. |
| Subpart B - Warning and Caution Statements for Drugs |
| § 369.20 - Drugs; recommended warning and caution statements. |
| § 369.21 - Drugs; warning and caution statements required by regulations. |
| § 369.22 - Drugs; warning and caution statements specifically required by law. |